During the 2014–2015 Ebola virus outbreak, which initiated in West Africa, a proof-of-concept trial with favipiravir was carried out in Guinea, and patients treated with favipiravir showed a trend towards improved survival.
1
—
—
During the 2014–2015 Ebola virus outbreak, which initiated in West Africa, a proof-of-concept trial with favipiravir was carried out in Guinea, and patients treated with favipiravir showed a trend towards improved survival.